Cancer vaccines enter a new era of personalized immunotherapy ++

Cancer vaccines enter a new era of personalized immunotherapy https://www.news-medical.net/news/20260122/Cancer-vaccines-enter-a-new-era-of-personalized-immunotherapy.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_27_january_2026 A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, and effective immunotherapies, particularly when combined with other cancer treatments. Whole-genome sequencing improves PARP inhibitor treatment prediction https://www.news-medical.net/news/20260112/Whole-genome-sequencing-improves-PARP-inhibitor-treatment-prediction.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=rare_diseases_newsletter_27_january_2026 A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.